Our People

Our senior leadership team comprises industry veterans with, in aggregate, more than a century of R&D experience across the full spectrum from top 10 pharma companies to start-up biotech ventures. Together, we can boast of having numerous INDs/CTAs in a wide variety of therapeutic areas and med chem modalities, as well as several successful BLAs/NDAs and M&A exits.

Click on each person to learn more.

Jim Gilbert, CEO

Jim Gilbert, MD

Shuhao Zhu, CSO

Shuhao Zhu, PhD

Shuhao Zhu, CSO

George Montgomery

Tia DeFeo-Fraulini, VP Clin & Reg Ops

VP Clin & Reg Ops
Tia DeFeo-Fraulini

Peter Cahill, General Counsel

General Counsel
Peter Cahill

Bob Schaub, PhD. SAB Chairman

SAB Chairman
Bob Schaub, PhD

Kristin Thompson, PhD. Director of Aptamer Discovery

VP Aptamer Discovery
Kristin Thompson, PhD

Paul Hatala, PhD. Head of CMC

Head of CMC
Paul Hatala, PhD

Peter Antoniuk, BS. Head of QA

Head of QA
Peter Antoniuk, BS


© 2023 Guardian Therapeutics. All rights reserved.

Welcome to the Guardian Therapeutics and Band Therapeutics website. We do not use any cookies or other technologies on this website, except those that are strictly necessary to enable normal functioning of this web page. View our data protection statement.

Guardian Therapeutics
101 Hartwell Avenue
Suite 2
Lexington, MA 02421
+1 (781) 918-6580

General Inquiries:

Business Development Inquiries: businessdevelopment@guardian-rx.com